Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Diazzi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Trends in Cancer|December 22, 2023
Nonepithelial cancer dissemination: specificities and challengesSerena Diazzi, Julien Ablain
Cancers|May 30, 2020
Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted TherapiesSerena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
Oncogenesis|February 11, 2023
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistanceSerena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
Non-Coding RNA|November 21, 2023
<i>LADON</i>, a Natural Antisense Transcript of <i>NODAL</i>, Promotes Tumour Progression and Metastasis in MelanomaAnnie Dutriaux, Serena Diazzi, Chiara Bresesti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2022
A role for metformin in the treatment of Dupuytren disease?Alberto Baeri, Michaël Levraut, Serena Diazzi, et al.
Oncogenesis|June 13, 2026
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathwayMargaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati, et al.
Cancer Research|May 3, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular CellsChristopher Rovera, Ilona Berestjuk, Margaux Lecacheur, et al.
Cell Death & Disease|October 6, 2025
Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activityKevin Berthenet, Serena Diazzi, Catherine Jamard, et al.
EMBO Molecular Medicine|December 27, 2021
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanomaIlona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, et al.
Cancer Research|March 18, 2020
A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant MelanomaChristophe A Girard, Margaux Lecacheur, Rania Ben Jouira, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Trends in Cancer|December 22, 2023
Nonepithelial cancer dissemination: specificities and challengesSerena Diazzi, Julien Ablain
Cancers|May 30, 2020
Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted TherapiesSerena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
Oncogenesis|February 11, 2023
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistanceSerena Diazzi, Sophie Tartare-Deckert, Marcel Deckert
Non-Coding RNA|November 21, 2023
<i>LADON</i>, a Natural Antisense Transcript of <i>NODAL</i>, Promotes Tumour Progression and Metastasis in MelanomaAnnie Dutriaux, Serena Diazzi, Chiara Bresesti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2022
A role for metformin in the treatment of Dupuytren disease?Alberto Baeri, Michaël Levraut, Serena Diazzi, et al.
Oncogenesis|June 13, 2026
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathwayMargaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati, et al.
Cancer Research|May 3, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular CellsChristopher Rovera, Ilona Berestjuk, Margaux Lecacheur, et al.
Cell Death & Disease|October 6, 2025
Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activityKevin Berthenet, Serena Diazzi, Catherine Jamard, et al.
EMBO Molecular Medicine|December 27, 2021
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanomaIlona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, et al.
Cancer Research|March 18, 2020
A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant MelanomaChristophe A Girard, Margaux Lecacheur, Rania Ben Jouira, et al.
Pageof 2